Phase 3 Trial of a Bivalent HPV Vaccine (Cecolin®) in Young Girls

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2021
This planned randomized controlled trial will evaluate a bivalent HPV vaccine, Cecolin®, in alternate 2-dose regimens, compared to an established HPV vaccine. Gardasil® used as the comparator vaccine, as this vaccine is most widely used in low- and low-middle income countries.
Epistemonikos ID: a693c54b29ce86769addd84fd75994de6853d774
First added on: May 07, 2024